Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.
Also called NCT01245374
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 103 participants
- Sponsor
- Registry
-
NCT01245374 -
2009-017387-16
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT01245374. Non-randomized; no masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2011-04 (actual). Results posted on 2012-06-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
- Condition
- Growth Hormone Disorder
- Condition
- Growth Hormone Deficiency in Children
- Condition
- Foetal Growth Problem
- Condition
- Small for Gestational Age
- Condition
- Genetic Disorder
- Condition
- Turner Syndrome
- Condition
- Chronic Kidney Disease
- Condition
- Chronic Renal Insufficiency
- Condition
- Delivery Systems
- Intervention (Device)
- Norditropin NordiFlex®
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct01245374- Content hash
e6df7a5734c50dd34214e04fb1d90b624020f93c6cd424d6c10777dc18d181e8